GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)
NCT03894020 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 83
Last updated 2024-10-30
Summary
An observational study to evaluate the natural progression of dry AMD in genetically defined subjects
Conditions
- Dry Age-related Macular Degeneration
- Macular Degeneration
- Retinal Disease
- Retinal Degeneration
- Geographic Atrophy
- Macular Atrophy
Sponsors & Collaborators
- collaborator INDUSTRY
-
Gyroscope Therapeutics Limited
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-08
- Primary Completion
- 2024-03-25
- Completion
- 2024-03-25
Countries
- United States
- Australia
- France
- Germany
- Netherlands
- Poland
- Spain
- United Kingdom
Study Locations
More Related Trials
-
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
NCT02399072 ·Status: TERMINATED
-
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
NCT03295877 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).
NCT05893537 ·Status: TERMINATED ·Phase: PHASE2
-
Carbidopa-Levodopa in Dry AMD With Geographic Atrophy
NCT03451500 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
NCT01342926 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration
NCT00090532 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
NCT05986864 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)
NCT04358471 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year
NCT03293524 ·Status: COMPLETED ·Phase: PHASE3
-
QA102 Phase II Study in Subjects With Dry AMD
NCT05536752 ·Status: COMPLETED ·Phase: PHASE2
-
Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy
NCT01003691 ·Status: COMPLETED ·Phase: PHASE1
-
A PhaseI/IIa Study to Determine the Safety and Tolerability of MA09-hRPE Cells in Patients With Advanced Dry AMD
NCT01674829 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa
NCT03326336 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Study of NGM621 in Participants With Geographic Atrophy
NCT04014777 ·Status: COMPLETED ·Phase: PHASE1
-
SGLT2 Inhibitors in Geographic Atrophy
NCT07174687 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
NCT01577381 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
NCT01535950 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration
NCT00429936 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of NGM621 in Participants With Geographic Atrophy
NCT04465955 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration
NCT02130531 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
NCT06659549 ·Status: RECRUITING ·Phase: PHASE2
-
A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7303359 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
NCT04615325 ·Status: COMPLETED ·Phase: PHASE1
-
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
NCT06346600 ·Status: RECRUITING
-
Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.
NCT06394232 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
NT-101 Topical Ophthalmic Solution in Patients With Wet AMD
NCT06704009 ·Status: COMPLETED ·Phase: PHASE1/PHASE2